Iman El-Hariry
Chief Tech/Sci/R&D Officer presso Erytech, Inc.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Iman El-Hariry is a professional with a doctorate degree from Alexandria Faculty of Medicine and Imperial College London.
She is currently the Chief Medical Officer at Erytech, Inc. Her former positions include Director-Clinical Development at Glaxo Smith Kline Biologicals NA, Vice President-Clinical Research at Synta Pharmaceuticals Corp., Global Head-Oncology at Astellas Pharma, Inc., Chief Medical Officer at ERYTech Pharma SA, and President at Azure Oncology Consulting LLC.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2022 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Iman El-Hariry
| Società | Posizione | Inizio |
|---|---|---|
| Erytech, Inc. | Chief Tech/Sci/R&D Officer | 15/07/2015 |
Precedenti posizioni note di Iman El-Hariry
| Società | Posizione | Fine |
|---|---|---|
Azure Oncology Consulting LLC
 Azure Oncology Consulting LLC Miscellaneous Commercial ServicesCommercial Services Azure Oncology Consulting LLC provides business consulting services. The private company is based in Boston. | President | 01/06/2015 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Chief Tech/Sci/R&D Officer | 01/07/2014 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 01/07/2010 |
Glaxo Smith Kline Biologicals NA
 Glaxo Smith Kline Biologicals NA Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Glaxo Smith Kline Biologicals NA is an American pharmaceutical company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01/07/2009 |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Chief Tech/Sci/R&D Officer | - |
Formazione di Iman El-Hariry
| Imperial College London | Doctorate Degree |
| Alexandria Faculty of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ASTELLAS PHARMA INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
Glaxo Smith Kline Biologicals NA
Glaxo Smith Kline Biologicals NA Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Glaxo Smith Kline Biologicals NA is an American pharmaceutical company that manufactures pharmaceutical products. | Health Technology |
| Erytech, Inc. | |
Azure Oncology Consulting LLC
Azure Oncology Consulting LLC Miscellaneous Commercial ServicesCommercial Services Azure Oncology Consulting LLC provides business consulting services. The private company is based in Boston. | Commercial Services |
- Borsa valori
- Insiders
- Iman El-Hariry
